EVP Capital Management AG
Overview
EVP Capital Management AG is a venture capital firm based in Frankfurt am Main, Germany, focusing on early-stage investments in technology and life sciences companies across the DACH region. The firm primarily invests in seed to Series C funding rounds, with investment sizes ranging from €1 million to €10 million. The firm's portfolio includes companies such as bio.logis, Phenex Pharmaceuticals, Signature Diagnostics GmbH, fg microtec, Nova Ratio, and iTAC Software. EVP Capital Management AG emerged from the management buyout of equinet Venture Partners AG in early 2008 and has been a 100% subsidiary of Co-Investor AG, Switzerland, since then.
Investment Focus
- Early-stage technology and life sciences companies in the DACH region
Portfolio Companies
Reach EVP Capital Management AG directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about EVP Capital Management AG
What sectors does EVP Capital Management AG invest in?
EVP Capital Management AG invests in Technology and Life Sciences, and is based in Hesse, Germany. EVP Capital Management AG is listed as a venture capital in the ConnectSafely investor database.
What stage does EVP Capital Management AG invest at?
EVP Capital Management AG backs companies at Seed, Early Stage, Series A and Series B, writing cheques of 1M - 10M.
Which regions does EVP Capital Management AG invest in?
EVP Capital Management AG invests across Germany, Switzerland and Austria.
What companies has EVP Capital Management AG invested in?
EVP Capital Management AG's portfolio includes Phenex Pharmaceuticals, bio.logis, Signature Diagnostics GmbH, fg microtec, Nova Ratio and iTAC Software.
Last updated · Source: ConnectSafely investor database
